Preoperative angiography-derived fractional flow reserve may predict coronary artery bypass grafting occlusion and disease progression.


Journal

Journal of cardiovascular medicine (Hagerstown, Md.)
ISSN: 1558-2035
Titre abrégé: J Cardiovasc Med (Hagerstown)
Pays: United States
ID NLM: 101259752

Informations de publication

Date de publication:
01 09 2023
Historique:
medline: 23 8 2023
pubmed: 22 8 2023
entrez: 22 8 2023
Statut: ppublish

Résumé

Graft occlusion after coronary artery bypass grafting (CABG) has been associated with competitive flow of native coronary arteries. To assess with coronary computed tomography angiography (CCTA) graft occlusion and coronary artery disease (CAD) progression of native vessels after CABG and their relationship with angiography-derived vessel fractional flow reserve (vFFR) performed before surgery. Between 2006 and 2018, serial vFFR analyses were obtained before CABG in each major native coronary vessel from two institutions. All patients underwent follow-up CCTA. In 171 consecutive patients, serial preoperative angiograms were suitable for vFFR analysis of 298 grafted and 59 nongrafted vessels. Median time between CABG and CCTA was 2.1 years. Preoperative vFFR was assessed in 131 left anterior descending artery (LAD), 132 left circumflex artery (LCX) and 94 right coronary aretry (RCA) and was less than 0.80 in 255 of 298 bypassed vessels. Graft occlusion was observed at CCTA in 28 of 298 grafts. The median preoperative vFFR value of native coronaries was higher in occluded compared with patent grafts (0.75 vs. 0.60, P < 0.001) and was associated with graft. The best vFFR cut-off to predict graft occlusion was 0.67. Progression of CAD was higher in grafted than in nongrafted vessels (89.6 vs. 47.5%, P < 0.001). Pre-CABG vFFR predicted disease progression of grafted native vessels (AUC = 0.83). Preoperative vFFR derived from invasive coronary angiography was able to predict graft occlusion and CAD progression of grafted coronary arteries.

Sections du résumé

BACKGROUND
Graft occlusion after coronary artery bypass grafting (CABG) has been associated with competitive flow of native coronary arteries.
OBJECTIVES
To assess with coronary computed tomography angiography (CCTA) graft occlusion and coronary artery disease (CAD) progression of native vessels after CABG and their relationship with angiography-derived vessel fractional flow reserve (vFFR) performed before surgery.
METHODS
Between 2006 and 2018, serial vFFR analyses were obtained before CABG in each major native coronary vessel from two institutions. All patients underwent follow-up CCTA.
RESULTS
In 171 consecutive patients, serial preoperative angiograms were suitable for vFFR analysis of 298 grafted and 59 nongrafted vessels. Median time between CABG and CCTA was 2.1 years. Preoperative vFFR was assessed in 131 left anterior descending artery (LAD), 132 left circumflex artery (LCX) and 94 right coronary aretry (RCA) and was less than 0.80 in 255 of 298 bypassed vessels. Graft occlusion was observed at CCTA in 28 of 298 grafts. The median preoperative vFFR value of native coronaries was higher in occluded compared with patent grafts (0.75 vs. 0.60, P < 0.001) and was associated with graft. The best vFFR cut-off to predict graft occlusion was 0.67. Progression of CAD was higher in grafted than in nongrafted vessels (89.6 vs. 47.5%, P < 0.001). Pre-CABG vFFR predicted disease progression of grafted native vessels (AUC = 0.83).
CONCLUSION
Preoperative vFFR derived from invasive coronary angiography was able to predict graft occlusion and CAD progression of grafted coronary arteries.

Identifiants

pubmed: 37605957
doi: 10.2459/JCM.0000000000001509
pii: 01244665-202309000-00009
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

651-658

Informations de copyright

Copyright © 2023 Italian Federation of Cardiology - I.F.C. All rights reserved.

Références

Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019; 40:87–165.
Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996; 28:616–626.
Wolk MJ, Bailey SR, Doherty JU, et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease. J Am Coll Cardiol 2014; 63:380–406.
Mushtaq S, Conte E, Pontone G, et al. Interpretability of coronary CT angiography performed with a novel whole-heart coverage high-definition CT scanner in 300 consecutive patients with coronary artery bypass grafts. J Cardiovasc Comput Tomogr 2019; 14:134–143.
Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics—2013 update. Circulation 2013; 127:e6–e245.
Berger A, MacCarthy Philip A, Siebert U, et al. Long-term patency of internal mammary artery bypass grafts. Circulation 2004; 110: (11_Suppl_1): II-36–II-40.
Nasu M, Akasaka T, Okazaki T, et al. Postoperative flow characteristics of left internal thoracic artery grafts. Ann Thorac Surg 1995; 59:154–161.
Sabik JF, Lytle BW, Blackstone EH, Khan M, Houghtaling PL, Cosgrove DM. Does competitive flow reduce internal thoracic artery graft patency? Ann Thorac Surg 2003; 76:1490–1497.
Maurer BJ, Oberman A, Holt JH Jr, et al. Changes in grafted and nongrafted coronary arteries following saphenous vein bypass grafting. Circulation 1974; 50:293–300.
Bourassa MG, Enjalbert M, Campeau L, Lesperance J. Progression of atherosclerosis in coronary arteries and bypass grafts: ten years later. Am J Cardiol 1984; 53:102c–107c.
Kroncke GM, Kosolcharoen P, Clayman JA, Peduzzi PN, Detre K, Takaro T. Five-year changes in coronary arteries of medical and surgical patients of the Veterans Administration Randomized Study of Bypass Surgery. Circulation 1988; 78 (3 pt 2):I144–I150.
Manninen HI, Jaakkola P, Suhonen M, Rehnberg S, Vuorenniemi R, Matsi PJ. Angiographic predictors of graft patency and disease progression after coronary artery bypass grafting with arterial and venous grafts. Ann Thorac Surg 1998; 66:1289–1294.
Pijls NHJ, Van Gelder B, Van der Voort P, et al. Fractional flow reserve. Circulation 1995; 92:3183–3193.
Xaplanteris P, Fournier S, Pijls NHJ, et al. FAME 2 Investigators. Five-year outcomes with PCI guided by fractional flow reserve. New Engl J Med 2018; 379:250–259.
Gigante C, Mizukami T, Sonck J, et al. Graft patency and progression of coronary artery disease after CABG assessed by angiography-derived fractional flow reserve. Int J Cardiol 2020; 316:19–25.
Asano T, Katagiri Y, Chang CC, et al. Angiography-derived fractional flow reserve in the SYNTAX II Trial. JACC: Cardiovasc Interv 2019; 12:259.
Taylor AJ, Cerqueira M, Hodgson JM, et al. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography: a report of the American College of Cardiology, Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Cardiovasc Comput Tomogr 2010; 4:407–433.
Narula J, Chandrashekhar Y, Ahmadi A, et al. SCCT 2021 Expert consensus document on coronary computed tomographic angiography: a report of the Society of Cardiovascular Computed Tomography. Review. J Cardiovasc Comput Tomogr 2021; 15:192–217.
Mushtaq S, Andreini D, Pontone G, et al. Prognostic value of coronary CTA in coronary bypass patients: a long-term follow-up study. JACC Cardiovasc Imaging 2014; 7:580–589.
Glineur D, Grau JB, Etienne PY, et al. Impact of preoperative fractional flow reserve on arterial bypass graft anastomotic function: the IMPAG trial. Eur Heart J 2019; 40:2421–2428.
Toth GG, De Bruyne B, Kala P, et al. Study design of the graft patency after FFR-guided versus angiography-guided CABG Trial (GRAFFITI). J Cardiovasc Transl Res 2018; 11:269–273.
Fournier S, Toth GG, De Bruyne B, et al. Six-year follow-up of fractional flow reserve-guided versus angiography-guided coronary artery bypass graft surgery. Circ Cardiovasc Interv 2018; 11:e006368.
Rupprecht HJ, Hamm C, Ischinger T, Dietz U, Reimers J, Meyer J. Angiographic follow-up results of a randomized study on angioplasty versus bypass surgery (GABI Trial). Eur Heart J 1996; 17:1192–1198.
Bourassa MG, Fisher LD, Campeau L, Gillespie MJ, McConney M, Lesperance J. Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Circulation 1985; 72:V71–V78.
Haley HA, Ghobrial M, Morris PD, et al. Virtual (computed) fractional flow reserve: future role in acute coronary syndromes. Front Cardiovasc Med 2021; 8:735008.
Deng MX, Lia H, Lee G, et al. Angiographic patency of coronary artery bypass conduits: an updated network meta-analysis of randomized trials. Braz J Cardiovasc Surg 2022; 37:7–31.

Auteurs

Saima Mushtaq (S)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Carlo Gigante (C)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Edoardo Conte (E)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Teresa Maria Capovilla (TM)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Jeroen Sonck (J)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.
Department of Advanced Biomedical Sciences, University of Naples, Federico II, Naples.

Alessandra Tanzilli (A)

La Sapienza University, Rome.

Emanuele Barbato (E)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.
Department of Advanced Biomedical Sciences, University of Naples, Federico II, Naples.

Giovanni Monizzi (G)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Marta Belmonte (M)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.

Bernard De Bruyne (B)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.

Antonio L Bartorelli (AL)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.
Department of Biomedical and Clinical Sciences.

Matteo Schillaci (M)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.
University of Milan, Milan.

Davide Marchetti (D)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.
University of Milan, Milan.

Maria Ludovica Carerj (ML)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.
Diagnostic and Interventional Radiology Unit, Department of Biomedical Sciences and Morphological and Functional Imaging, 'G. Martino' University Hospital Messina, Messina.

Gianluca Pontone (G)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.
Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.

Carlos Collet (C)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.

Daniele Andreini (D)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.
Department of Biomedical and Clinical Sciences.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH